A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

Clinical trial NCT05028478 · UNKNOWN

Trial details

NCT number: NCT05028478
Sponsor: Curon Biopharmaceutical (Australia) Co Pty Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor Hematologic Malignancies

Start date: 2021-10-22
Primary completion: 2023-02-10
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.